Korean Market
OWNR
Samjin Pharmaceutical
★
Executive Sangjin Kim increases stake to 0.08% via open market purchase of 3,000 shares at KRW 17,869
 15h ago
OWNR
Samjin Pharmaceutical
★
Non-Registered Director Shin Seung-won Acquires 600 Common Shares via Open Market (0.00% Stake)
 15h ago
PERI
Samjin Pharmaceutical
★
Samjin Pharmaceutical Q1 2026: Sales -3.9%, Operating Profit -25.8%, R&D Investment Expands (12.24% of Sales)
 05/15/2026, 04:06 PM
EXCH
Samjin Pharmaceutical
★★
2025 Annual Individual Financial Results: Revenue Slightly Up (+0.3%) but Net Profit Plunges 39.5%
 05/10/2026, 07:00 PM